The neuroprotective actions of corticotropin releasing hormone.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Ageing Research Reviews

• Publication date

  2005-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.ARR.2005.02.004PMID 16046283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system.

  2005cited by this paper
• Cognitive Corticotropin-Releasing Factor and Urocortin I Modulate Excitatory Glutamatergic Synaptic Transmission

  2004cited by this paper
• Corticotropin releasing factor enhances survival of cultured GABAergic cerebellar neurons after exposure to a neurotoxin.

  2004cited by this paper
• Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  2004cited by this paper
• Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.

  2003cited by this paper
• Crosstalk between Rap1 and Rac regulates secretion of sAPPα

  2003cited by this paper
• Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons.

  2003cited by this paper
• High‐Quality Antidepressant Discovery by Understanding Stress Hormone Physiology

  2003cited by this paper
• Corticotropin‐releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases

  2003cited by this paper
• Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists.

  2002cited by this paper
• Potential signalling pathways underlying corticotrophin‐releasing hormone‐mediated neuroprotection from excitotoxicity in rat hippocampus

  2002cited by this paper
• Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals.

  2002cited by this paper
• The CRF peptide family and their receptors: yet more partners discovered.

  2002cited by this paper
• Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB.

  2002cited by this paper
• The Pros and Cons of Apoptosis Assays for Use in the Study of Cells, Tissues, and Organs

  2002cited by this paper
• Urocortin, But Not Urocortin II, Protects Cultured Hippocampal Neurons from Oxidative and Excitotoxic Cell Death via Corticotropin-Releasing Hormone Receptor Type I

  2002cited by this paper
• Rat cerebral cortex corticotropin‐releasing hormone receptors: evidence for receptor coupling to multiple G‐proteins

  2001cited by this paper
• NF-kappaB in neuronal plasticity and neurodegenerative disorders.

  2001cited by this paper
• Calcium regulation of neuronal gene expression

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• The cell biology of Alzheimer's disease: uncovering the secrets of secretases.

  2001cited by this paper
• Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.

  2001cited by this paper
• The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats

  2001cited by this paper
• NF-κB in neuronal plasticity and neurodegenerative disorders

  2001cited by this paper
• Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro.

  2000cited by this paper
• Dexamethasone-enhanced sensitivity of mouse hippocampal HT22 cells for oxidative stress is associated with the suppression of nuclear factor-kappaB.

  2000cited by this paper
• Glycogen Synthase Kinase-3β Activity Is Critical for Neuronal Death Caused by Inhibiting Phosphatidylinositol 3-Kinase or Akt but Not for Death Caused by Nerve Growth Factor Withdrawal*

  2000cited by this paper
• Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB.

  2000cited by this paper
• Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic ß-precursor protein and with the suppression of nuclear factor κB.

  2000cited by this paper
• Corticotropin-releasing factor produces a protein synthesis--dependent long-lasting potentiation in dentate gyrus neurons.

  2000cited by this paper
• The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

  1999cited by this paper
• Corticotropin-Releasing Factor Type 1 and Type 2α Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase.

  1999cited by this paper
• Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2

  1999cited by this paper
• Neuropeptide abnormalities in patients with early Alzheimer disease.

  1999cited by this paper
• Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression.

  1999cited by this paper
• The role of corticotropin-releasing factor in depression and anxiety disorders.

  1999cited by this paper
• Corticotropin-releasing hormone receptor subtypes and emotion.

  1999cited by this paper
• Neurotrophins and hippocampal synaptic transmission and plasticity

  1999cited by this paper
• Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.

  1999cited by this paper
• CRH-like peptides protect cardiac myocytes from lethal ischaemic injury.

  1999cited by this paper
• Transcription factor NF-kappaB: friend or foe of neurons?

  1998cited by this paper
• High Constitutive NFk B Activity Mediates Resistance to Oxidative Stress in Neuronal Cells

  1998cited by this paper
• Corticotrophin‐releasing factor produces a long‐lasting enhancement of synaptic efficacy in the hippocampus

  1998cited by this paper
• Transcription factor NF-κB: friend or foe of neurons?

  1998cited by this paper
• Janus faces of NF-κB: Neurodestruction versus neuroprotection

  1997cited by this paper
• Janus faces of NF-kappa B: neurodestruction versus neuroprotection.

  1997cited by this paper
• Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.

  1996cited by this paper
• Corticotropin-releasing hormone stimulates Ca2+ entry through L- and P-type Ca2+ channels in rat corticotropes.

  1996cited by this paper
• Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.

  1996cited by this paper
• In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

  1996cited by this paper
• Physiology of the neurotrophins.

  1996cited by this paper
• Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

  1995cited by this paper
• Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders.

  1995cited by this paper
• Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Expression cloning of a human corticotropin-releasing-factor receptor.

  1993cited by this paper
• Neuroprotection by Corticotropin Releasing Factor During Hypoxia in Rat Brain

  1993cited by this paper
• Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.

  1991cited by this paper
• Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

  1990cited by this paper
• CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.

  1989cited by this paper
• Cerebrospinal fluid concentrations of corticotropin‐releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

  1987cited by this paper
• Reductions in corticotropin releasing factor‐like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy

  1987cited by this paper
• Immunohistochemical study of neurons containing corticotropin‐releasing factor in Alzheimer's disease

  1987cited by this paper
• Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

  1986cited by this paper
• Spinal fluid CRF reduction in Alzheimer's disease.

  1986cited by this paper
• Corticotropin-Releasing Factor-like Immunoreactivity in Senile Dementia of the Alzheimer Type: Reduced Cortical and Striatal Concentrations

  1985cited by this paper
• Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.

  1985cited by this paper
• Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.

  1983cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

  1982cited by this paper
• Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

  1981cited by this paper

• Untangling the complex mechanisms associated with Alzheimer's disease in elderly patients using high-throughput RNA sequencing data and next-generation knowledge discovery methods: Focus on potential gene signatures and drugs for dementia

  2024cites this paper
• Single-cell analysis of the aging female mouse hypothalamus

  2022cites this paper
• Single cell analysis of the aging female hypothalamus

  2022cites this paper
• Corticotropin-releasing factor protects against ammonia neurotoxicity in isolated larval zebrafish brains

  2020cites this paper
• Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review

  2020cites this paper
• G-Protein coupled receptors and tau-different roles in alzheimer's disease.

  2020cites this paper
• A high fructose diet alters affective-like behavior and metrics of synaptic mitochondrial function differentially in male and female rats

  2019cites this paper
• Vulnerability and resilience to Alzheimer’s disease: early life conditions modulate neuropathology and determine cognitive reserve

  2018cites this paper
• Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression

  2018cites this paper
• Corticotropin-releasing factor regulates caspase-3 and may protect developing zebrafish from stress-induced apoptosis.

  2018cites this paper
• Endogenous glucocorticoids: role in the etiopathogenesis of Alzheimer's disease.

  2017cites this paper
• Sex-dependent mental illnesses and mitochondria.

  2017cites this paper
• LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice

  2016cites this paper
• Corticotropin-releasing hormone receptor 1 in the prefrontal cortex conveys acute stress-induced executive dysfunction

  2015cites this paper
• Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease

  2014cites this paper
• Metabolic Syndrome as a Risk Factor for Alzheimer Disease

  2013cites this paper
• Metabolic Syndrome

  2013cites this paper
• Corticotropin-Releasing Factor Receptor 1 Activation During Exposure to Novelty Stress Protects Against Alzheimer's Disease-Like Cognitive Decline in AβPP/PS1 Mice

  2013cites this paper
• Molecular Insights into Appetite Control and Neuroendocrine Disease as Risk Factors for Chronic Diseases in Western Countries

  2013cites this paper
• Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities.

  2013cites this paper
• Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient

  2013cites this paper
• Voluntary exercise regionally augments rates of cerebral protein synthesis.

  2013cites this paper
• Hypothalamic-Pituitary-Adrenal Axis in Gastrointestinal Physiology

  2012cites this paper
• Auswirkungen des Polymorphismus rs3176921 im CRH-Gen auf kognitive Phänotypen

  2011cites this paper
• Neurotrophic signaling molecules associated with cholinergic damage in young and aged rats: environmental enrichment as potential therapeutic agent.

  2011cites this paper
• Therapeutic potential of some stress mediators in early Alzheimer's disease.

  2011influential citation
• Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy

  2011cites this paper
• Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase.

  2011cites this paper
• Molecular signaling and translational significance of the corticotropin releasing factor system.

  2011cites this paper
• The Corticotropin‐Releasing Hormone in Neuroprotection

  2011cites this paper
• Corticotropin‐releasing factor‐2 activation prevents gentamicin‐induced oxidative stress in cells derived from the inner ear

  2010cites this paper
• Increased connexin 43 expression as a potential mediator of the neuroprotective activity of the corticotropin-releasing hormone.

  2009cites this paper
• Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.

  2009cites this paper
• 82 – Neuroregulatory Peptides of Central Nervous System Origin: From Laboratory to Clinic

  2009cites this paper
• Ontogeny of the corticotropin-releasing factor system in zebrafish.

  2009cites this paper
• Hormones in the mentally disturbed brain: steroids and peptides in the development and treatment of psychopathology.

  2009cites this paper
• Der Einfluss des Hepatitis B Virus X-assoziierten Protein 2 (XAP2) auf die Funktion des Glukokortikoidrezeptors

  2008cites this paper
• Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.

  2008cites this paper
• Loss of a child and the risk of amyotrophic lateral sclerosis.

  2007cites this paper
• Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain.

  2007cites this paper
• The Prefrontal Cortex as a Key Target of the Maladaptive Response to Stress

  2007cites this paper
• Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation

  2007influential citation
• Relation between Corticotropin-Releasing Hormone Neuron Number in the Hypothalamic Paraventricular Nucleus and Depressive State in Alzheimer’s Disease

  2007cites this paper
• [Risk factors and protective factors of the insanities].

  2007cites this paper
• Facteurs de risque et facteurs protecteurs des démences

  2007cites this paper
• Zur Funktion der Corticotropin releasing hormone Rezeptoren in der Maus

  2006cites this paper
• No evidence of CRHR1 gene involvement in progressive supranuclear palsy.

  2006cites this paper
• The search for novel avenues for the therapy and prevention of Alzheimer's disease.

  2006cites this paper
• Ageing and neuronal vulnerability

  2006cites this paper